secwatch / observer
8-K filed December 21, 2023, 6:59 PM ET ticker SDEV CIK 0001389545
other material confidence high sentiment negative materiality 0.85

NovaBay reprices Series B warrants to $0.25, raises ~$554K; anti-dilution adds 23.4M shares

Stablecoin Development Corp

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Stablecoin Development Corp entered into Letter Agreements with existing holders of Series B-1 warrants and Series B-2 warrants valued at Issuance of new Series C Common Stock purchase warrants; anti-dilution adjustment triggered (effective 2023-12-21).

Action
entry
Agreement
equity purchase
Counterparty
existing holders of Series B-1 warrants and Series B-2 warrants
Value
Issuance of new Series C Common Stock purchase warrants; anti-dilution adjustment triggered
Effective
2023-12-21
Exact text from the filing
On December 21, 2023, NovaBay Pharmaceuticals, Inc. (the “ Company ”) announced that on December 21, 2023, it entered into letter agreements (the “ Letter Agreements ”) with certain of existing holders of its Series B-1 warrants (the “ Series B-1 Warrants ”) to purchase Company common stock, par value $0.01 per share (“ Common Stock ”) and its the Series B-2 warrants (the “ Series B-2 Warrants ” and together with the Series B-1 Warrants, the “ Series B Warrants ”) to purchase Common Stock that were issued to such holders pursuant to a Securities Purchase Agreement, dated April 27, 2023.
View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Stablecoin Development Corp filing history →

Source: SEC EDGAR
accession 0001437749-23-035032
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.